A case of neonatal lupus presenting with myocardial dysfunction with complete heart block: early identification and management results in excellent outcome
DOI:
https://doi.org/10.18203/2349-3291.ijcp20251767Keywords:
Neonatal lupus, Congenital complete atrioventricular block, Ventricular dysfunction, MyocarditisAbstract
Neonatal lupus erythematosus (NLE) is an uncommon acquired autoimmune disorder that develops when maternal autoantibodies to Sjogren’s syndrome A or B (SSA-SSB) autoantigens pass through placenta and cause immune mediated destruction of targeted fetal and neonatal tissues. Among the cardiac abnormalities, congenital complete atrioventricular block (AVB) is the most common cardiovascular abnormality seen in affected fetuses and infants that also accounts for more than 80% of cases of complete AVB in newborns with structurally normal heart. Other cardiovascular manifestations may include arrhythmias, myocarditis, cardiomyopathy and structural heart defects with particular tendency toward valvular lesions. We report a case of a neonate who presented with severe ventricular dysfunction with ejection fraction 20% in the presence of complete heart block (CHB), required extracorporeal membrane oxygenation (ECMO support). After treatment with pulse steroids and IVIG, there was a dramatic improvement in ejection fraction 55%. ECMO support was successfully weaned, and a permanent pacemaker was subsequently inserted. The neonate was discharged home in good health.
Metrics
References
Zuppa AA, Riccardi R, Frezza S, Gallini F, Luciano RM, Alighieri G, et al. Neonatal lupus: follow-up in infants with anti-SSA/Ro antibodies and review of the literature. Autoimmun Rev. 2017;16(4):427-32. DOI: https://doi.org/10.1016/j.autrev.2017.02.010
Costedoat-Chalumeau N, Amoura Z, Lupoglazoff J-M, Huong DL, Denjoy I, Sebbouh D, et al. Outcome of pregnancies in patients with anti-SSA/Ro antibodies: a study of 165 pregnancies, with special focus on electrocardiographic variations in the children and comparison with a control group. Arthritis Rheum 2004;50(10):3187-94.
Brucato A, Cimaz R, Caporali R, Ramoni V, Buyon J. Pregnancy outcomes in patients with autoimmune diseases and anti-Ro/SSA antibodies. Clin Rev Allergy Immunol. 2011;40(1):27-41. DOI: https://doi.org/10.1007/s12016-009-8190-6
Sukumaran S, Singh D. Cutaneous neonatal lupus erythematosus: a case report. Cureus. 2022;14(2):e22279. DOI: https://doi.org/10.7759/cureus.22279
Glickstein JS, Buyon J, Friedman D. Pulsed Doppler echocardiographic assessment of the fetal PR interval. Am J Cardiol. 2000;86(2):236-9. DOI: https://doi.org/10.1016/S0002-9149(00)00867-5
Buyon JP, Clancy RM, Friedman DM. Cardiac manifestations of neonatal lupuserythematosus: guidelines to management, integrating clues from the bench and bedside. Nat Clin Pract Rheumatol. 2009;5(3):139-48. DOI: https://doi.org/10.1038/ncprheum1018
Costedoat-Chalumeau N, Amoura Z, Lupoglazoff J-M, Huong D, Denjoy I, Vauthier D, et al. Outcome of pregnancies in patients with anti-SSA/Ro antibodies: a study of 165 pregnancies, with special focus on electrocardiographic variations in the children and comparison with a control group. Arthritis Rheum 2004;50(10):3187-94. DOI: https://doi.org/10.1002/art.20554
Buyon JP, Clancy RM. Neonatal lupus syndromes. Curr Opin Rheumatol. 2003;15(5):535-41. DOI: https://doi.org/10.1097/00002281-200309000-00003
Wisuthsarewong W, Soongswang J, Chantorn R. Neonatal lupus erythematosus: clinical character, investigation, and outcome. Pediatr Dermatol. 2011;28(2):115-21. DOI: https://doi.org/10.1111/j.1525-1470.2011.01300.x
Jaeggi ET, Hamilton RM, Silverman ED, Zamora S, Hornberger L. Outcome of children with fetal, neonatal or childhood diagnosis of isolated congenital atrioventricular block. A single institution’s experience of 30 years. J Am Coll Cardiol. 2002;39(1):130-7. DOI: https://doi.org/10.1016/S0735-1097(01)01697-7
Balmer C, Fasnacht M, Rahn M, Molinari L, Bauersfeld U. Long-term follow up of children with congenital complete atrioventricular block and the impact of pacemaker therapy. Europace. 2002;4(4):345-9. DOI: https://doi.org/10.1053/eupc.2002.0266
Trucco SM, Jaeggi E, Cuneo B, Moon-Grady AJ, Silverman E, Silverman N, et al. Use of intravenous gamma globulin and corticosteroids in the treatment of maternal autoantibody-mediated cardiomyopathy. J Am Coll Cardiol. 2011;57(6):715-23. DOI: https://doi.org/10.1016/j.jacc.2010.09.044
Nield LE, Silverman E, Smallhorn JF, Taylor GP, Mullen JB, Silverman NH, et al. Endocardial fibroelastosis associated with maternalanti-Ro and anti-la antibodies in the absence of atrioventricular block. J Am Coll Cardiol. 2002;40(4):796-802. DOI: https://doi.org/10.1016/S0735-1097(02)02004-1
Hornberger LK, Rajaa NA. NA Spectrum of cardiac involvement in neonatal lupus. Scand J Immunol. 2010;72(3):189-97. DOI: https://doi.org/10.1111/j.1365-3083.2010.02437.x
Nield LE, Silverman ED, Taylor GP, Smallhorn JF, Mullen JB, Silverman NH, et al. Maternal anti-Ro and anti-La antibody-associated endocardial fibroelastosis. Circulation. 2002;105(7):843-8. DOI: https://doi.org/10.1161/hc0702.104182
Moak JP, Barron KS, Hougen TJ, Wiles HB, Balaji S, Sreeram N, et al. Congenital heart block: development of late-onset cardiomyopathy, a previously underappreciated sequela. J Am Coll Cardiol. 2001;37(1):238-42. DOI: https://doi.org/10.1016/S0735-1097(00)01048-2
Downloads
Published
How to Cite
Issue
Section
